A clinical research article presenting a nomogram-based prediction tool for clinicians to assess 90-day risk of unfavorable outcomes after IV thrombolysis in minor ischemic stroke patients, helping guide early decision-making and resource use.
Key Takeaways
- Data were extracted from the Multicenter Clinical Trial of Revascularization Treatment for Acute Ischemic Stroke (TRAIS)
- While several clinical trials have demonstrated the potential benefits of IVT in this population ( 12 )
- Previous studies have identified multiple factors associated with unfavorable outcomes in MIS patients undergoing IVT